Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Petrini

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
Hematological Oncology|October 21, 2020
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myelomaSerena Rocchi, Paola Tacchetti, Lucia Pantani, et al.
Cancers|June 22, 2023
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell LymphomaGabriele Perrone, Luigi Rigacci, Sara Urru, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphomaFranck Morschhauser, John Radford, Achiel Van Hoof, et al.
Cancers|February 15, 2022
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela StudyBeatrice Casadei, Lisa Argnani, Alessandro Broccoli, et al.
British Journal of Haematology|May 17, 2012
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortiumDaniele Campa, Alessandro Martino, Juan Sainz, et al.
Frontiers in Oncology|December 22, 2018
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid LeukemiaSara Galimberti, Susanna Grassi, Claudia Baratè, et al.
American Journal of Hematology|March 18, 2024
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working partiesStefano Giardino, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Blood|June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphomaSimone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.
Oncotarget|July 21, 2016
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysisRafael Ríos-Tamayo, Carmen Belén Lupiañez, Daniele Campa, et al.
Blood Advances|April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trialMarina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
Hematological Oncology|October 21, 2020
A real-world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myelomaSerena Rocchi, Paola Tacchetti, Lucia Pantani, et al.
Cancers|June 22, 2023
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell LymphomaGabriele Perrone, Luigi Rigacci, Sara Urru, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2008
Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphomaFranck Morschhauser, John Radford, Achiel Van Hoof, et al.
Cancers|February 15, 2022
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela StudyBeatrice Casadei, Lisa Argnani, Alessandro Broccoli, et al.
British Journal of Haematology|May 17, 2012
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortiumDaniele Campa, Alessandro Martino, Juan Sainz, et al.
Frontiers in Oncology|December 22, 2018
The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid LeukemiaSara Galimberti, Susanna Grassi, Claudia Baratè, et al.
American Journal of Hematology|March 18, 2024
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working partiesStefano Giardino, Dirk-Jan Eikema, Brian Piepenbroek, et al.
Blood|June 23, 2022
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase 3 trial in mantle cell lymphomaSimone Ferrero, Daniele Grimaldi, Elisa Genuardi, et al.
Oncotarget|July 21, 2016
A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysisRafael Ríos-Tamayo, Carmen Belén Lupiañez, Daniele Campa, et al.
Blood Advances|April 12, 2022
Idasanutlin plus cytarabine in relapsed or refractory acute myeloid leukemia: results of the MIRROS trialMarina Y Konopleva, Christoph Röllig, Jamie Cavenagh, et al.
Pageof 26